E-LIB Suche - Ergebnisse für: Yasuhara, Hidenori

1

Reduction of Off-Target Effects of Gapmer Antisense Oligonu..:

Yasuhara, Hidenori ; Yoshida, Tokuyuki ; Sasaki, Kiyomi..
Molecular Diagnosis & Therapy. 26 (2022) 1 - p. 117-127 , 2022

Link: https://doi.org/10.1007/..

2

Metabolomic profiling of urine-derived extracellular vesicl..:

Saito, Masayoshi ; Horie, Satoshi ; Yasuhara, Hidenori...
Biochemical and Biophysical Research Communications. 546 (2021) - p. 103-110 , 2021

Link: https://doi.org/10.1016/..

3

Prediction of human pharmacokinetics for low‐clearance comp..:

Yoshida, Kosuke ; Doi, Yuki ; Iwazaki, Norihiko...
Clinical and Translational Science. 15 (2021) 1 - p. 79-91 , 2021

Link: https://doi.org/10.1111/..

4

Evaluation of off‐target effects of gapmer antisense oligon..:

Yoshida, Tokuyuki ; Naito, Yuki ; Yasuhara, Hidenori...
Genes to Cells. 24 (2019) 12 - p. 827-835 , 2019

Link: https://doi.org/10.1111/..

5

Evaluation of the effects of chemically different linkers o..:

Wada, Shunsuke ; Yasuhara, Hidenori ; Wada, Fumito...
Journal of Controlled Release. 226 (2016) - p. 57-65 , 2016

Link: https://doi.org/10.1016/..

6

DNA/RNA heteroduplex oligonucleotide for highly efficient g..:

Nishina, Kazutaka ; Piao, Wenying ; Yoshida-Tanaka, Kie...
Nature Communications. 6 (2015) 1 - p. , 2015

Link: https://doi.org/10.1038/..

7

Amido-bridged nucleic acids with small hydrophobic residues..:

Yamamoto, Tsuyoshi ; Yahara, Aiko ; Waki, Reiko...
Organic & Biomolecular Chemistry. 13 (2015) 12 - p. 3757-3765 , 2015

Link: https://doi.org/10.1039/..

8

Locked nucleic acid antisense inhibitor targeting apolipopr..:

Yamamoto, Tsuyoshi ; Obika, Satoshi ; Nakatani, Moeka...
European Journal of Pharmacology. 723 (2014) - p. 353-359 , 2014

Link: https://doi.org/10.1016/..

9

Superior Silencing by 2′,4′-BNANC-Based Short Antisense Oli..:

Yamamoto, Tsuyoshi ; Yasuhara, Hidenori ; Wada, Fumito...
Journal of Nucleic Acids. 2012 (2012) - p. 1-7 , 2012

Link: https://doi.org/10.1155/..

10

Cholesterol-lowering Action of BNA-based Antisense Oligonuc..:

Yamamoto, Tsuyoshi ; Harada-Shiba, Mariko ; Nakatani, Moeka...
Molecular Therapy - Nucleic Acids. 1 (2012) - p. e22 , 2012

Link: https://doi.org/10.1038/..

11

Reduction of Off-Target Effects of Gapmer Antisense Oligonu..:

Yasuhara, Hidenori ; Yoshida, Tokuyuki ; Sasaki, Kiyomi..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766371/. , 2022

Link: http://www.ncbi.nlm.nih...

12

Prediction of human pharmacokinetics for low‐clearance comp..:

Yoshida, Kosuke ; Doi, Yuki ; Iwazaki, Norihiko...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742647/. , 2021

Link: http://www.ncbi.nlm.nih...

13

Evaluation of off‐target effects of gapmer antisense oligon..:

Yoshida, Tokuyuki ; Naito, Yuki ; Yasuhara, Hidenori...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6915909/. , 2019

Link: http://www.ncbi.nlm.nih...

14

DNA/RNA heteroduplex oligonucleotide for highly efficient g..:

Nishina, Kazutaka ; Piao, Wenying ; Yoshida-Tanaka, Kie...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918363/. , 2015

Link: http://www.ncbi.nlm.nih...

15

Cholesterol-lowering Action of BNA-based Antisense Oligonuc..:

Yamamoto, Tsuyoshi ; Harada-Shiba, Mariko ; Nakatani, Moeka...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3393380. , 2012

Link: http://www.ncbi.nlm.nih...